Literature DB >> 4401050

Glucagon in heart failure and in cardiogenic shock. Experience in 50 patients.

R Lvoff, D E Wilcken.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4401050     DOI: 10.1161/01.cir.45.3.534

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  7 in total

1.  Treatment of Aluminium Phosphide Poisoning with a Combination of Intravenous Glucagon, Digoxin and Antioxidant Agents.

Authors:  Zohreh Oghabian; Omid Mehrpour
Journal:  Sultan Qaboos Univ Med J       Date:  2016-08-19

2.  The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects.

Authors:  Roberto Vettor; Silvio E Inzucchi; Paola Fioretto
Journal:  Diabetologia       Date:  2017-01-11       Impact factor: 10.122

3.  Digitalis-induced increase in aortic regurgitation and the contrasting effect of glucagon in the sedated dog.

Authors:  B E Hopkins; R R Taylor
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

Review 4.  Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.

Authors:  Julia Schumann; Eva C Henrich; Hellen Strobl; Roland Prondzinsky; Sophie Weiche; Holger Thiele; Karl Werdan; Stefan Frantz; Susanne Unverzagt
Journal:  Cochrane Database Syst Rev       Date:  2018-01-29

Review 5.  Adverse effects of contrast media: incidence, prevention and management.

Authors:  H S Thomsen; W H Bush
Journal:  Drug Saf       Date:  1998-10       Impact factor: 5.606

6.  Glucagonoma-induced acute heart failure.

Authors:  Kun Zhang; Lukas J Lehner; Damaris Praeger; Gert Baumann; Fabian Knebel; Marcus Quinkler; Torsten K Roepke
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2014-11-01

7.  Does glucagon have a positive inotropic effect in the human heart?

Authors:  Jesus Hernández-Cascales
Journal:  Cardiovasc Diabetol       Date:  2018-11-27       Impact factor: 9.951

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.